BIO

(2′Z,3′E)-6-Bromoindirubin-3′-oxime

(3E)-6′-BROMO-2,3′-BIINDOLE-2′,3(1H,1′H)-DIONE 3-OXIME

(3Z)-6-Brom-3-[(3E)-3-(hydroxyimino)-1,3-dihydro-2H-indol-2-yliden]-1,3-dihydro-2H-indol-2-on

(3Z)-6-Bromo-3-[(3E)-3-(hydroxyimino)-1,3-dihydro-2H-indol-2-ylidene]-1,3-dihydro-2H-indol-2-one

(3Z)-6-Bromo-3-[(3E)-3-(hydroxyimino)-1,3-dihydro-2H-indol-2-ylidène]-1,3-dihydro-2H-indol-2-one

2H-Indol-2-one, 6-bromo-3-[(3E)-1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-1,3-dihydro-, (3Z)-

6-BIO

6-Bromoindirubin-3′-oxime

667463-62-9

6BIO

BIO

MFCD08705318

(2Z,3E)-6-Bromoindirubin-3′-oxime

(2Z,3E)-6′-bromo-2,3′-biindole-2′,3(1H,1′H)-dione 3-oxime

(2Z,3E)-6′-bromo-3-(hydroxyimino)-[2,3′-biindolinylidene]-2′-one

(3Z)-6-Bromo-3-[(3E)-3-hydroxyimino-1H-indol-2-ylidene]-1H-indol-2-one

(Z)-6′-Bromo-1H,1′H-[2,3′]biindolylidene-3,2′-dione 3-oxime

-oxime

2H-Indol-2-one,6-bromo-3-[(3E)-1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-1,3-dihydro-,(3Z)-

6-bromo-3-[(2Z,3E)-3-(hydroxyimino)-1H-indol-2-ylidene]-1H-indol-2-one

6-bromo-3-[(2Z,3E)-3-(hydroxyimino)-2,3-dihydro-1H-indol-2-ylidene]-2,3-dihydro-1H-indol-2-one

6-bromo-3-[(3E)-3-(hydroxyimino)-2,3-dihydro-1H-indol-2-ylidene]-2,3-dihydro-1H-indol-2-one

6-Bromoindirubin-3-oxime

6BIO;6-BIO;GSK 3 IX;GSK 3 Inhibitor IX;MLS 2052;MLS2052

95%

GSK 3 Inhibitor IX

GSK 3 IX

GSK-3 Inhibitor IX

GSK-3InhibitorIX

Z,3ʹ